Featured post

SCS research and awards news

For all our research and awards news, please visit our news page.

Monday 4 June 2018

Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial

Arun Azad et al. published in the Journal of Hematology & Oncology.

No comments:

Post a Comment